CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts
CISH is a negative regulator of IL-13-induced CCL26 production in lung fibroblasts
复制标题
CISH 是肺成纤维细胞中 IL-13 诱导的 CCL26 产生的负调节因子
DOI:
10.1016/j.alit.2018.08.005
复制
发表时间:
2019
影响因子:
6.8
通讯作者:
Yamauchi Yasuhiro
中科院分区:
文献类型:
--
作者:
Takeshima Hideyuki;Horie Masafumi;Mikami Yu;Makita Kosuke;Miyashita Naoya;Matsuzaki Hirotaka;Noguchi Satoshi;Urushiyama Hirokazu;Hiraishi Yoshihisa;Mitani Akihisa;Borok Zea;Nagase Takahide;Yamauchi Yasuhiro
Background: Bronchial asthma is a chronic airway disease characterized by eosinophilic airway inflammation. Lung fibroblasts activated by IL-13 serve as important sources of chemokines, such as eotaxins, contributing to persistent eosinophilic inflammation. Src-homology 2-containing protein (CISH), belonging to the suppressor of cytokine signaling (SOCS) family, acts as a negative regulator of cytokine induction. The aim of this study was to elucidate the role of CISH in the production of eosinophil chemotactic chemokines in human lung fibroblasts.Methods: Normal human lung fibroblasts were stimulated by IL-13, and global gene expression profile was assessed by cDNA microarray. Expression changes and downstream of IL-13 signaling were evaluated by quantitative RT-PCR, ELISA or western blotting. Loss-and gain-of-function analyses of CISH were performed by small interfering RNA and vector overexpression, respectively.Results: Ingenuity pathway analysis revealed that IL-13 induced chemokine signaling, including the eotaxin family, while significantly suppressing IFN-α/β signaling. Among eight SOCS family members, CISH was most strongly induced by IL-13 via phosphorylation of signal transducer and activator of transcription 6 (STAT6). Loss-and gain-of-function studies demonstrated that CISH negatively regulated the expression of CCL26.Conclusions: These findings suggest that CISH plays a key role in the eosinophilic inflammation associated with bronchial asthma by regulating IL-13-induced CCL26 production. Augmentation of CISH function could be a novel approach for treating eosinophilic inflammation in severe asthma.